Shares of Niagen Bioscience (NAGE) are soaring 6.25% in early trading on Thursday, building on the momentum from pre-market activity. The surge comes in response to the company's announcement of a $10 million share repurchase program, which has ignited investor interest and confidence in the bioscience firm.

The share repurchase program, revealed early Thursday morning, authorizes Niagen Bioscience to buy back up to $10 million worth of its outstanding common stock. This strategic move is being viewed favorably by investors, as such programs can potentially increase the value of remaining shares and signal management's confidence in the company's financial health and future prospects.

Analysts suggest that this move by Niagen Bioscience could be interpreted as a sign that the company believes its stock is undervalued. The significant uptick in share price indicates that investors are responding positively to this development, seeing it as a bullish signal for the company's future performance. As trading continues, market participants will be closely watching to see if this momentum can be sustained throughout the session.